Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism
- 1 May 1993
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 67 (5), 945-952
- https://doi.org/10.1038/bjc.1993.175
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- The Significance of Bleeding Patterns in Norplant Implant UsersObstetrics & Gynecology, 1991
- The Selectivity of a New ProgestinActa Obstetricia et Gynecologica Scandinavica, 1990
- The Risk of Breast Cancer after Estrogen and Estrogen–Progestin ReplacementThe New England Journal of Medicine, 1989
- Contrasting ability of antiestrogens to inhibit MCF-7 growth stimulated by estradiol or epidermal growth factorEuropean Journal of Cancer and Clinical Oncology, 1989
- Biology and mode of action of pure antioestrogensJournal of Steroid Biochemistry, 1988
- Oral-Contraceptive Use and the Risk of Breast CancerThe New England Journal of Medicine, 1986
- Clinical Pharmacokinetics of Oral Contraceptive SteroidsClinical Pharmacokinetics, 1983
- Decreased Risk of Endometrial Cancer among Oral-Contraceptive UsersThe New England Journal of Medicine, 1980
- Incidence of Endometrial Cancer in Relation to the Use of Oral ContraceptivesThe New England Journal of Medicine, 1980
- A case control study of carcinoma of the ovary.Journal of Epidemiology and Community Health, 1977